Mirtazapine
Product Images NDC 64725-0003

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 64725-0003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 0003)

Label for Mirtazapine 30 mg tablets showing prescription-only status. The label includes a barcode, lot number, expiration date placeholders, manufacturer listed as Aurolife, and repackager as TYA Pharmaceuticals, with address in Tallahassee, FL, and a phone number.*

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Chemical structure diagram of mirtazapine showing its molecular framework with labeled atoms and bonds, including a methyl group attached to a nitrogen atom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.